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Ras proteins are distributed in different types of plasma membrane microdomains and endomembranes.
However, how microlocalization affects the signals generated by Ras and its subsequent biological outputs
is largely unknown. We have approached this question by selectively targeting RasV12 to different cellular
sublocalizations. We show here that compartmentalization dictates Ras utilization of effectors and the
intensity of its signals. Activated Ras can evoke enhanced proliferation and transformation from most of
its platforms, with the exception of the Golgi complex. Furthermore, signals that promote survival
emanate primarily from the endoplasmic reticulum pool. In addition, we have investigated the need for the
different pools of endogenous Ras in the conveyance of upstream mitogenic and transforming signals.
Using targeted RasN17 inhibitory mutants and in physiological contexts such as H-Ras/N-Ras double
knockout fibroblasts, we demonstrate that Ras functions at lipid rafts and at the Golgi complex are fully
dispensable for proliferation and transformation.
Ras GTPases—H-Ras, N-Ras, and K-Ras 4B/4A—operate
as key molecular switches that convey extracellular signals
from surface receptors to the interior of the cell, thereby reg-
ulating essential processes including proliferation, differentia-
tion, and survival (15, 34). It is well known that Ras must be
attached to the inner leaflet of the plasma membrane (PM) to
be functional (50). This is accomplished by lipidic additions to
the protein C terminus (33), which contains the essential signal
for localizing Ras to membranes: the CAAX box (where C is
cysteine, A is alyphatic amino acid, and X is serine/methio-
nine). This motif undergoes posttranslational modifications
that make it more hydrophobic. The cysteine is farnesylated,
the AAX sequence is proteolyzed, and the newly C-terminal
cysteine is carboxymethylated (50). However, a second signal is
necessary for efficiently positioning Ras in the membrane. This
is accomplished by palmitoylation of cysteine 181 in N-Ras,
and cysteines 181 and 184 in H-Ras. In the case of K-Ras 4B
the second signal is attained by a polybasic motif of six lysines
(175 to 180) that interacts electrostatically with the negatively
charged membrane (24–26).
Recently, a new twist has been provided by findings indicat-
ing that Ras isoforms are distinctively segregated in different
PM microdomains with unique biochemical and physicochem-
ical characteristics, H-Ras can be found in bulk membrane and
in lipid rafts, both caveolar and noncaveolar. K-Ras is exclu-
sively located in bulk membrane, whereas N-Ras can only be
detected in noncaveolar lipid rafts (35, 38–40). Furthermore,
recent reports indicate that Ras is also present in endomem-
branes such as endosomes, endoplasmic reticulum (ER), and
the Golgi complex (10, 37, 45). The significance of this distri-
bution seems to go beyond that of a transient event associated
to transport and/or recycling. Instead, a pool of Ras appears to
reside in these organelles, and therein Ras can productively
engage downstream effectors (10, 11, 37, 45). Moreover, at
these endomembranes Ras regulation is undertaken by pro-
teins that operate in a location-specific fashion. As such, the
guanine nucleotide exchange factor RasGRP specifically reg-
ulates Ras activation at the Golgi complex (7, 9), whereas SOS
and RasGRF undertake Ras regulation at the ER. Likewise,
stimuli such as lysophosphatidic acid preferentially activate the
Ras pool at the ER, whereas calcium ionophores are more
effective in activating PM Ras (4).
The fact that exogenous stimuli activate Ras distinctively
depending on its localization and that Ras regulation at differ-
ent sites requires the participation of specific intermediaries
hints at the necessity for a location-specific control. This, in
term, may imply that Ras functions at its different sites may not
be totally redundant. Thus, a selective activation of Ras at each
of its locations could be intended to generate variability in its
biochemical and biological outputs. It is known that Ras reg-
ulates numerous cellular functions through the activation of an
ever-growing number of effector molecules (15). However,
how microlocalization affects the biochemical signals that Ras
* Corresponding author. Mailing address: Instituto de Investigaciones
Biome´dicas, Consejo Superior de Investigaciones Cientı´ficas (CSIC).
Unidad de Biomedicina, CSIC-Universidad de Cantabria. Departamento
de Biologı´a Molecular Facultad de Medicina, C/ Cardenal Herrera Oria
s/n, Santander 39011, Spain. Phone: 34-942-200959. Fax: 34-942-201945.
E-mail: pcrespo@iib.uam.es.
† D.M. and V.S.-M. contributed equally to this study.
100
 o
n
 N
ovem
ber 13, 2012 by Red de Bibliotecas del CSIC
http://m
cb.asm
.org/
D
ow
nloaded from
 
generates and the biological outputs that it regulates is just
beginning to be unfolded (23). Herein, we have addressed that
question. We present for the first time a systematic study on
the differences in effectors utilization resulting from Ras activ-
ity at specific cellular sites. In addition, we also demonstrate
how activation or inhibition of Ras restricted to defined mem-
brane systems and microdomains affects biological outcomes
such as cellular proliferation, survival, and transformation.
Overall, the present study moves one step beyond into under-
standing how compartmentalization of Ras signals affects its
performance and identifies those cellular sites where Ras is
essential for cellular proliferation and transformation.
MATERIALS AND METHODS
Constructs. pEXV H-RasV12 C181,184 S (SS) was provided by J. F. Hancock;
pGEX-Ral-RBD was provided by J. L. Bos; and pCEFL-m1 was provided by J. S.
Gutkind. Plasmids encoding for v-Sis and v-Src have been described (29). pCEFL
hemagglutinin (HA) vectors harboring the targeting signals M1, KDELr, and
CD8 have been described (4). KDELr N193D was generated by PCR-directed
mutagenesis. Oligonucleotides encoding LCK myristoylation signal were cloned
in pCEFL-HA, directly upstream of the HA tag. Tethering constructs expressing
FLAG, instead of HA tag, were also synthesized. H-RasV12 SS and H-RasN17
SS were amplified by PCR and cloned into pCEFL-HA or pCEFL-FLAG tar-
geting constructs, respectively. SSS mutants were generated by PCR-directed
mutagenesis (QuikChange; Promega), introducing the C186S mutation into the
targeted V12 constructs. All constructs were verified by DNA sequencing. Se-
quences of the oligonucleotides utilized are available upon request. Interleukin-1
and adriamycin were from Preprotech.
Cell culture. HEK293T, COS-7, MDCK, and NIH 3T3 cells were grown in
Dulbecco modified Eagle medium (DMEM)–10% fetal calf serum (calf serum
for NIH 3T3). Mouse embryo fibroblasts (MEFs) were grown in DMEM–10%
donor calf serum–0.1 mM nonessential amino acids (NEAA) –55 M -mer-
captoethanol. Stable lines cells were generated by transfection with Lipo-
fectamine (Invitrogen) according to the manufacturer’s instructions and selected
with 750 g of G418/ml. 293T and COS-7 cells were transiently transfected with
calcium phosphate (46).
Kinase assays. Extracellular signal-regulated kinase 2 (ERK2) and JNK kinase
activities were determined in anti-ERK and anti-JNK immunoprecipitates using
as substrates myelin basic protein (Sigma) or glutathione S-transferase (GST)–
ATF2, respectively (3). Akt kinase assays were performed as described previ-
ously (17) in cells transiently transfected with a plasmid encoding for HA-tagged
Akt in anti-HA immunoprecipitates, using histone H2B as substrate.
Antibodies. Mouse monoclonal anti-HA was from Babco; rabbit polyclonal
anti-FLAG was from Invitrogen. Rabbit polyclonal anti-calreticulin was from
Calbiochem. Antigiantin mouse monoclonal antibodies were supplied by H. P.
Hauri (Basel, Switzerland). Mouse monoclonal anti-transferrin receptor and
antitubulin were from Zymed. Mouse monoclonal anti-Ecto-5-nucleotidase was
from BD Biosciences. Rabbit polyclonal anti-Akt and goat polyclonal anti-phos-
pho-Akt were from Cell Signaling, and rabbit polyclonal anti-Raf has been
previously described (16). Goat polyclonal antibody anti-Ral A and rabbit poly-
clonal antibodies anti-HA anti-ERK2, anti-RasGRF1, anticaveolin, anti-PARP,
anti-TC21, anti-H-Ras, anti-K-Ras, and anti-N-Ras were from Santa Cruz
Laboratories.
Immunoblotting. Total lysates and immunoprecipitates were fractionated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto
nitrocellulose filters as described previously (4). Immunocomplexes were visual-
ized by enhanced chemiluminescence detection (Amersham) by using horserad-
ish peroxidase-conjugated secondary antibodies (Cappel).
Focus assays. NIH 3T3 and MEF cells were cultured in DMEM supplemented
with 10% calf serum. NIH 3T3 cells were transfected by using the calcium
phosphate technique as described previously (16). MEFs were transfected with
Lipofectamine (Invitrogen) according to the manufacturer’s instructions. After
10 to 15 days in culture (15 to 20 days for MEFs), cells were fixed and stained,
and the foci were scored.
G418-resistant colonies assays. NIH 3T3 cells were transfected with calcium
phosphate and grown in the presence of 750 g of G418/ml. After 10 to 15 days
plates were fixed and stained, and colonies with a diameter greater than 2 mm
were scored.
Immunofluorescence. M1 and KDELr cells lines were washed in phosphate-
buffered saline (PBS) and fixed in 3.7% paraformaldehyde. Preparations were
sequentially incubated with 0.1 M glycine-PBS for 10 min, permeabilized with
0.5% Triton X-100–PBS for 15 min, and PBS–0.01% Tween 20 for 5 min. CD8
and LCK cell lines were fixed with ice-cold 3.7% paraformaldehyde in PBS and
washed with cold PBS without permeabilization. In all cases, preparations were
incubated for 1 h with primary antibodies or cholera toxin fluorescein isothio-
cyanate (FITC; Sigma-Aldrich) that recognizes ganglioside GM1, washed, and
incubated for 45 min with secondary antibodies conjugated to FITC or Texas red.
Confocal microscopy was performed with a Bio-Rad MRC-1024 at excitation
wavelengths of 488 nm (FITC) or 543 nm (Texas red).
Sucrose gradients. Cells were collected and resuspended in 25 mM Tris (pH
7.4), 150 mM NaCl, 5 mM EDTA, and 0.25% Triton X-100, with rocking at 4°C
for 1 h. Lysates were set to a sucrose concentration of 41%. Layers of 8.5 ml of
35% sucrose (in 10 mM Tris [pH 7.4]) and of 2.5 ml of 16% sucrose were
sequentially overlaid and centrifuged in a Beckman SW41 rotor for 18 h at 35,000
rpm. We collected 10 to 11 1-ml fractions, precipitated them in 6.5% trichloro-
acetic acid, resuspended them in loading buffer, and fractionated them by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis using 12% gels. Membrane
solubilizations in sodium carbonate and subsequent fractionations were per-
formed exactly as described previously (38).
Ras-GTP loading assays. Performed as described previously (5). Ras-GTP was
affinity sequestered by using GST-Raf RBD (amino acids 1 to 149). Immunoblots
were performed with anti-HA antibody and quantitated by densitometry using
the program NIH Image 1.60. Ras-GTP levels were related to total Ras protein
levels as determined by anti-HA immunoblotting in the corresponding total
lysates.
Ral GTP assays. Ral GTP assays were performed as described previously (52).
Briefly, cells were lysed in 15% glycerol, 1% NP-40, 50 mM Tris (pH 7.4), 200
mM NaCl, 2.5 mM MgCl2, and protease/phosphatase inhibitors, followed by
incubation for 45 min with 10 to 15 g of GST-Ral RBD. Immunoblots were
performed as described above with anti-Ral A antibody and quantitated by
densitometry.
Measurement of proliferation and survival rates. Cells were plated at low
density in six-well plates (10,000 cells/per plate) and grown in different serum
conditions as indicated. Cells were detached and scored by standard cell counting
techniques at the indicated intervals.
RESULTS
Selective tethering of H-Ras V12 to defined sublocalizations.
To investigate the differences in Ras functions at sites where it
is present, it was necessary to activate it precisely at, and only
at, the desired subcellular localizations. For this purpose we
generated constructs that encoded for constitutively active
H-RasV12 fused to specific tethering signals. First, we gener-
ated a palmitoylation-deficient H-RasV12 by mutating cys-
teines 181 and 184 to serines (H-RasV12 SS). This mutant is
not efficiently retained at the PM and exists in a dynamic
equilibrium shuttling between the ER and cytoplasmic pools
(10). The palmitoylation signal was then substituted by alter-
native cues that would specifically direct H-RasV12 SS to the
desired locations. To deliver it to the ER, we fused to its N
terminus amino acids 1 to 66 of the avian infectious bronchitis
virus M protein (M1) (49) (referred to as M1-V12). We sent
H-RasV12 SS to the Golgi complex, by means of an N-termi-
nally fused KDEL receptor (KDELr) (9). Since KDELr is an
itinerant protein that recycles to the ER, mutation N193D was
introduced. This mutation prevents it from redistributing to
the ER and renders it a resident Golgi protein (13) (named
KDELr-V12). At the PM, we wanted to discriminate between
events regulated from bulk membrane and from lipid rafts. As
such, H-RasV12 SS was tethered to bulk membrane by placing in
its N terminus the transmembrane domain of the CD8 receptor,
known to locate exclusively in this type of PM (2) (referred to as
CD8-V12 hereafter). Finally, to target H-RasV12 SS to lipid rafts,
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we utilized an N-terminal myristoylation signal. Unpalmitoylated
myristoylation signals, like that of Rasheed sarcoma virus, cannot
retain farnesylated Ras at the membrane (8), whereas palmitoy-
lated myristoylation signals, such as the one of LCK (42), act as
effective lipid raft anchors (48). An HA tag was included to
enable the detection of these proteins.
These constructs were stably expressed in NIH 3T3 cells,
and polyclonal pools, in which more than 80% of the cells
stained positive for HA (data not shown), were utilized for
further experimentation. In these, the localization of the tar-
geted Ras proteins was ascertained by immunofluorescence
with anti-HA antibodies. Cells expressing H-RasV12 exhibited
a typical spindle-shaped morphology. In these, H-RasV12 was
evident at the PM outlining the cells, in addition to endomem-
branes such as the Golgi complex (Fig. 1A, arrowhead) and the
ER network, more prominently in the perinuclear area. In
contrast, in cells expressing H-RasV12 SS Ras was absent from
peripheral PM, and it exhibited a diffuse staining characteristic
of cytoplasmic proteins, although staining at the nuclear enve-
lope, typical of ER localization, was also clear (Fig. 1B). On
the other hand, ER-tethered M1-V12 displayed a typical re-
ticular distribution with a complete absence of cytoplasmic
staining and was undetectable at the PM and at the Golgi com-
plex (Fig. 1C). KDELr-V12 expression was clearly restricted to
the Golgi apparatus and was absent from the PM and the ER
(Fig. 1D). CD8-V12 was localized in patches throughout the
PM, as shown in a tangential confocal plane in Fig. 1E and,
within the cell body, in vesicular structures, resembling endo-
somes. However, it was undetectable at the ER (not shown).
Finally, LCK-V12 also exhibited a peripheral membrane stain-
ing at defined patches. Small vesicles, probably lipid raft-de-
rived endosomes, were also apparent, but no ER staining was
evident (Fig. 1F). Even though Ras proteins are known to be
subject to a fast, dynamic shuttling between PM and the Golgi
complex (11), we could not detect LCK or CD8-tethered Ras
proteins at the Golgi complex (Fig. 1E and F and data not
shown). These results pointed to the correct localization of our
targeted Ras proteins. Interestingly, these staining patterns,
with virtually no mislocalization, were also detected in COS-7
and 293T cells, even though in these cells our plasmids yielded
much higher expression levels (data not shown).
To ascertain beyond doubt that our targeted Ras proteins
were correctly localized, we analyzed their colocalization with
bona fide markers of the aimed compartments. As we have
previously demonstrated, M1- and KDELr-targeted Ras pro-
teins displayed a profuse costaining with the ER marker cal-
reticulin and the Golgi marker giantin, respectively (4; data not
shown). In the same fashion, CD8-V12 and LCK-V12 were
FIG. 1. Subcellular localization of targeted Ras proteins. (A to F) Representative confocal micrographs of NIH 3T3 cells stably transfected with
the indicated constructs, immunostained with anti-HA. As indicated by the symbol in the upper right corner, all panels show equatorial sections
at the cell nucleus level, except panel E, which shows a tangential plane. Scale bars: A, 5 m; B to F, 10 m. (G to J) Colocalization of CD8-V12
(G and H) and LCK-V12 (I and J) with lipid rafts and bulk membrane markers. Ras proteins were revealed by anti-HA (red in panels G, H and
J; green in panel H), costained with anti-transferrin receptor as a bulk membrane marker (green, panels G and J), and anti-5-nucleotidase (red,
panel H) or FITC-cholera toxin (green, panel I) as raft markers. As indicated by the symbol in the upper right corner, all panels show tangential
or semitangential planes, except panel J that shows an equatorial section at the cell nucleus level. Bars: G, I, and J, 20 m; H, 15 m.
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detected at, and only at, the expected PM microdomains. As
such, CD8-V12 markedly colocalized with the transferrin re-
ceptor, a marker for disordered membrane (Fig. 1G), but an
absolute lack of colocalization with the lipid raft marker 5
nucleotidase was evident (Fig. 1H). Conversely, LCK-V12
strongly merged with the raft marker ganglioside GM1, as
shown in a tangential confocal plane (Fig. 1I), but no costain-
ing with the transferrin receptor was apparent (Fig. 1J). Fur-
ther proof for the correct localization of these constructs was
provided by experiments in which membranes of the targeted-
Ras-transfected cells were solubilized in low concentrations of
Triton X-100 and fractionated in sucrose gradients. As ex-
FIG. 1—Continued.
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pected, LCK-V12 cofractionated with the lipid raft marker
caveolin in the lighter fractions, whereas CD8-V12 could only
be detected in disordered membrane fractions, characterized
by the presence of the transferrin receptor. On the other hand,
neither M1-V12 nor KDELr-V12 could be detected on either
lipid raft or disordered membrane fractions, demonstrating the
lack of contamination of the peripheral membrane with the
endomembrane-targeted constructs (Fig. 2A). Solubilization in
sodium carbonate yielded identical results (data not shown).
Overall, these results clearly indicated that our targeted H-
RasV12 proteins were specifically localized at the desired mi-
crodomains.
It was important to acquire some notion of the relative
expression levels that each targeted protein attained. By im-
munoblotting for HA expression it was found that, as expected,
all of the targeted-V12 proteins were expressed at lower levels
than those of H-Ras V12, widespread throughout all of the
sublocalizations, or of H-Ras V12 SS, which accumulated to
high levels in the cytoplasm. Noticeably, the PM proteins,
LCK-V12 and CD8-V12, were expressed at slightly higher lev-
els than those of M1-V12 and KDELr-V12, located at endo-
membranes (Fig. 2B). As such, we wanted to know whether
these differences were a consequence of variations in the in-
trinsic expression potentials of each of the constructs. When
expressed in vitro in a reticulocyte system, these constructs
yielded very similar expression levels (data not shown), some-
thing that argued against this concept. Alternatively, the pos-
sibility existed that the expression levels of the targeted pro-
teins were a reflection of how much Ras could be inserted on
each type of membrane. In our unpalmitoylated constructs, the
remaining Ras-specific determinant for membrane localization
was their farnesyl moiety. Thus, we introduced the mutation
C186S that rendered them farnesylation deficient as well. It
was found that, regardless of the targeting signal, these pro-
teins (termed SSS) achieved much higher expression levels
than their respective palmitoylation-deficient (SS) constructs,
as shown for M1-V12 (Fig. 2B, lower panel). Interestingly, a
significant proportion of the SSS proteins had lost their specific
localization and was detected at the cytoplasm (data not
shown). Overall, these results indicated that a Ras membrane
localization determinant was important for defining both the
expression levels and the localization of our targeted proteins.
Targeted Ras proteins can effectively engage effectors in
vitro and in vivo. It was essential to verify that the addition of
a more or less bulky targeting signal to the N terminus of
H-RasV12 did not compromise its GTP-bound state and there-
fore its ability to engage effectors. Initially, we tested the be-
havior of the targeted Ras proteins in a standard in vitro
effector binding assay; these were expressed in 293T cells, and
the GTP-bound fractions were affinity pulled-down by using
the c-Raf Ras binding domain (RBD) bound to glutathione
beads. It was found that untargeted H-RasV12 and the differ-
ent location-specific RasV12 proteins bound to GST-RBD
with very similar efficiencies (data not shown). Next, we ascer-
tained whether the targeted Ras proteins could also bind to
effectors in vivo. In the NIH 3T3 cell lines we examined
whether the presence of site-specific RasV12 proteins brought
about colocalization with c-Raf at defined sites. In cells ex-
pressing H-Ras wild-type, H-Ras could be detected at PM, ER,
and Golgi complex, as expected. c-Raf displayed a diffuse
staining, typical of a cytoplasmic protein, but no colocalization
was apparent at any of these sites under serum starvation
conditions (Fig. 3A). In sharp contrast, under the same condi-
tions, in M1-V12-expressing cells a clear Ras/Raf colocaliza-
tion was present throughout the reticular network (Fig. 3B). A
marked costaining was also apparent in LCK-V12- and CD8-
FIG. 2. Localization and expression of targeted Ras proteins.
(A) Subcellular fractionation of targeted Ras proteins. NIH 3T3 cells
stably expressing the different targeted Ras constructs were solubilized
in 0.25% Triton X-100 and partitioned in a sucrose gradient as de-
scribed in Materials and Methods. The presence of the targeted Ras
proteins in the different fractions was analyzed by anti-HA immuno-
blotting. Anti-caveolin-1 immunoblotting identified the lipid raft frac-
tions; anti-transferrin receptor immunoblotting identified the disor-
dered membrane fractions. In the fractionations corresponding to cells
expressing KDELr-V12 and M1-V12, a total lysate (TL) was run
alongside as a control. (B) Expression levels of the targeted Ras pro-
teins as determined by anti-HA-immunoblotting in total lysates from
the NIH 3T3 cells lines stably expressing the Ras constructs. The
middle panel shows tubulin expression levels as a loading control. The
bottom panel shows a comparison of the expression levels of M1-V12
unpalmitoylated (SS) versus unpalmitoylated, unfarnesylated (SSS)
proteins, as determined by anti-HA-immunoblotting in total lysates
from COS-7 cell lines transfected with the indicated constructs.
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V12-expressing cells, but in these cases, merging took place
primarily at the peripheral PM and to a lesser extent in endo-
somes (Fig. 3C and D). Surprisingly, in KDELr-V12-express-
ing cells the colocalization between Raf and Ras at the Golgi
complex was very poor (Fig. 3E), even though, as stated above,
KDELr-V12 could effectively bind to c-Raf RBD in vitro.
Overall, our results demonstrated that the addition of tether-
ing signals did not compromise RasV12 functionality, both in
FIG. 3. Colocalization of c-Raf with targeted Ras proteins. Serum-starved NIH 3T3 cells expressing the indicated Ras constructs were costained
with anti-HA and anti-Raf antibodies. (A) No colocalization with c-Raf is observed in cells expressing H-Ras wild type (wt). (B) M1-V12 displays
high colocalization with c-Raf at the ER. (C and D) Colocalization of Raf with LCK- and CD8-V12 at the PM and endosomes. (E) Limited
colocalization of c-Raf with KDELr-V12 at the Golgi complex. Confocal sections at the level of the nucleus are shown in all panels. In panels B
to D, insets highlight areas of prominent colocalization (arrows). Bars: A, C, and D, 20 m; B, 10 m; E, 15 m.
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vitro and at the different subcellular localizations, and vali-
dated these constructs for further experimentation.
Distinct pools of RasV12 elicit different biochemical signals.
It was of interest to investigate whether signaling pathways
triggered by Ras were equally activated irrespective of Ras
localization or, alternatively, different cellular pools of Ras
evoked distinct signals. For that purpose, in the NIH 3T3 lines
stably expressing the targeted RasV12 constructs we analyzed
FIG. 4. Ras effector usage at distinct compartments. (A) Activation of ERK2 by targeted Ras constructs. Serum-starved, NIH 3T3 cells stably
expressing the indicated constructs were processed as indicated in Materials and Methods. Kinase assays were performed in anti-ERK2
immunoprecipitates, with myelin basic protein as a substrate. ERK levels were determined by immunoblotting with anti-ERK2 antibodies. Bar
chart shows the average  the standard error of the mean (SEM) of at least five experiments relative to the phosphorylation levels detected in
control cells. (B) Activation of Akt. Determined by immunoblotting in serum-starved cells, with antibodies to phosphorylated Akt or by kinase
assays with histone H2B as the substrate. The bar chart shows the average  the SEM of at least five experiments, relative to the H2B
phosphorylation levels detected in control cells. (C) Activation of Ral GTPase. Ral GTP pull-down assays were performed in cell lysates as
indicated in Materials and Methods and revealed by anti-Ral immunoblotting. Total Ral levels were determined in lysates with the same antibody.
The data show the averages  the SEM of at least five independent experiments relative to the Ral-GTP levels in control cells. (D) Activation
of JNK. Kinase assays were performed with GST-ATF2 as substrate. The levels of JNK were determined by immunoblotting with anti-JNK
antibody. The data show the results (average  the SEM) of at least five experiments relative to ATF2 phosphorylation levels found in control
cells. analysis of variance was performed by using the Bonferroni multiple comparison test relative to the respective “V12” values. P values:
, P  0.05; , P  0.01; , P  0.001; NS, P  0.05 with a 95% confidence interval.
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the activation status of several well-known Ras effector path-
ways. When we studied the activation of the ERK cascade,
pronounced differences were detected depending on the cel-
lular site from which the Ras signal originated. H-RasV12 SS,
a protein loosely held to the ER, showed a reduced ability to
activate ERKs (Fig. 4A), as previously demonstrated (8). How-
ever, firmly anchoring Ras to the ER, as was the case for
M1-V12, elicited a potent activation of ERKs. LCK-V12, at
lipid rafts, was capable of activating ERKs to similar levels,
while bulk membrane CD8-RasV12 displayed a lower, though
significant, ability to activate this route. Interestingly, very little
activation of ERKs was detected when the Ras signal ema-
nated from the Golgi complex, as that one generated by
KDELr-V12, in agreement with the low colocalization of Ras
and Raf in this organelle. A similar situation was encountered
when we studied the PI3KAkt pathway. In this case, Ras
signals originating at the ER and at lipid rafts were the most
effective for activating this route (Fig. 4B). Ras capacity to acti-
vate Akt from the disordered membrane was noticeably reduced.
Once more Ras located at the Golgi complex was the least effi-
cient for activating Akt. Curiously, this pattern was reversed when
we looked at the activation of Ral-GDS. In this case, the Golgi
complex was the platform from which Ral-GDS was most effec-
tively activated, followed by the bulk membrane (Fig. 4C). Even
though the JNK pathway is not considered a bona fide Ras ef-
fector route, in NIH 3T3 cells JNK can be activated by Ras to
some extent (14). Thus, we also tested how Ras compartmental-
ization affected the activation of this route. Interestingly, it was
found that endomembranes, both ER and Golgi, were the sites
preferred by Ras to activate JNK (Fig. 4D), whereas the Ras
pools present at PM microdomains were considerably less effec-
tive for activating this mitogen-activated protein kinase. Assays
FIG. 5. Compartmentalized Ras activation effects on cellular pro-
liferation. (A) Proliferation rate of the NIH 3T3 cells lines expressing
the indicated Ras constructs growing in media supplemented with 5%
calf serum. (B and C) Proliferation rates of three clones (C1 to C3)
isolated from the M1-V12 (B) and the LCK-V12 (C) polyclonal cell
lines compared to their respective total pools. (D) Effects of targeted
Ras V12 constructs on colony growth. NIH 3T3 fibroblasts were trans-
fected with the indicated constructs (0.25 g) and selected in the
presence of G418 (750 g/ml). After 2 weeks in culture, colonies were
stained, and those with a diameter greater than 0.05 mm were scored.
In all cases, results show the average  the SEM of at least three
independent experiments.
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similar to those just described were also performed in 293T cells
under transient-transfection conditions. Noticeably, the results
obtained were identical to those just described (data not shown).
We needed to ascertain that the signals elicited by the tar-
geted RasV12 proteins were directly generated by Ras itself
and were not secondary signals, consequences of autocrine
loops induced by Ras activation. To test this, conditioned me-
dia from cells expressing the site-specific Ras constructs were
collected after 12 and 24 h and added to parental NIH 3T3
cells, and effector activation was assayed. In no case was the
conditioned medium able to induce any significant ERK, Akt,
or Ral-GDS activation (data not shown), thus demonstrating
that the signals detected in the aforementioned experiments
were a consequence of RasV12 direct effects.
Distinct pools of RasV12 differentially regulate cellular pro-
liferation, survival, and transformation. We wanted to deter-
mine whether variations in effector usage and in signal magni-
tude at the distinct Ras signaling platforms translated into
different biological responses. First, we evaluated how cellular
proliferation was affected by location-restricted Ras signaling
by comparing the proliferation rates of the cell lines expressing
the targeted Ras constructs when growth occurred under stan-
dard culture conditions. We found that most of the pools
displayed similar growth curves (Fig. 5A), with a proliferating
profile that resembled that one of H-RasV12-transfected cells
(doubling time of 13.4 h). The remarkable exception was the
line expressing Golgi complex-tethered KDELr-V12, which
exhibited much slower growth kinetics (doubling time of
19.6 h), similar to those encountered in control cells. It was
important to ascertain to what extent the behavior of the poly-
clonal cell lines was representative of the clonal population
that they were made up of. To this end, the growth kinetics of
three isolated clones extracted from each of the polyclonal
lines was compared to those of their respective pools. As
shown for M1-V12 (Fig. 5B) and for LCK-V12 (Fig. 5C), no
significant differences were encountered among the prolifera-
tion rates of the pools and of the isolated clones. Likewise, no
substantial variations were apparent in the cases of KDELr-
V12 and CD8-V12 either (data not shown).
The ability of the tethered Ras proteins for supporting pro-
liferation was tested further by colony growth assays. As such,
the targeted Ras constructs were transfected into NIH 3T3
cells and after G418 selection the arising colonies were scored.
In line with the previous data, all of the targeted Ras construct
yielded a number of colonies similar to that of H-Ras V12 (Fig.
5D), with the exception of KDELr-V12, for which the potential
to form colonies was similar to that of vector-transfected cells
and significantly lower than that of H-Ras wild type.
We also wanted to investigate how compartmentalized Ras
activity affected cell survival. To this aim, the NIH 3T3 cell
lines were deprived of serum, and their ability to survive in
these conditions was monitored. As shown in Fig. 6A, in the
absence of growth factors RasV12, irrespective of its localiza-
tion, supported proliferation for almost two complete doubling
cycles. Eventually, all lines reached crisis, and cell numbers
started dropping with similar kinetics, with the exception of
cells harboring ER-tethered M1-V12, in which the rate of cell
death was remarkably lower. This behavior was mirrored to
some extent by the cell line expressing H-RasV12 SS. Even
though this cell line reached crisis before the rest, its death
kinetics were noticeably slower.
We extended this observation by analyzing the consequences
of compartmentalized Ras activity when cells were challenged
with defined apoptogenic stimuli. For this purpose, the NIH
3T3 cell lines were treated with interleukin-1 to induce cell
death. It was found that apoptosis, as monitored by the deg-
radation of poly(ADP-ribose) polymerase (PARP), was prom-
inent in the cell lines expressing Ras V12 and the targeted V12
constructs, with the exception of the cells harboring ER-teth-
ered M1-V12, in which apoptosis was remarkably forestalled
(Fig. 6B, top panel). To rule out that this phenomenon was
FIG. 6. Effects of compartmentalized Ras activation on cellular
survival and transformation. (A) Survival rate of the NIH 3T3 cell lines
expressing the indicated Ras constructs in the absence of growth fac-
tors. Cells were cultured in media supplemented with 0.1% calf serum.
Cells were collected at the indicated times and counted. The results
represent average  the SEM of at least three independent experi-
ments. (B) Antiapoptotic effects of site-specific Ras activation. NIH
3T3 and MDCK cells stably expressing the Ras targeted constructs
were treated with interleukin-1 (10 g/ml) for 24 h and with adriamy-
cin (5 M) for 16 h, respectively. PARP degradation was monitored in
total lysates by anti-PARP immunoblotting. (C) Cellular transforma-
tion induced by site-specific Ras constructs. NIH 3T3 fibroblasts were
transfected with the indicated constructs (100 ng) by the calcium phos-
phate technique. Foci were stained and scored after 2 weeks in culture.
Numbers indicate average number of foci per microgram of DNA 
the SEM of at least three independent experiments.
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limited to a given cell type, we generated lines of MDCK
epithelial cells stably expressing the targeted Ras constructs. In
this cellular model, Ras activation restricted to the ER also
conferred a remarkable resistance to cell death, as induced by
treatment with the proapoptotic drug adriamycin (Fig. 6B,
bottom panel).
Finally, we looked at whether sublocalization affected H-
RasV12 transformation potential. For this purpose, the ability
of the targeted RasV12 constructs to generate transformed
foci in NIH 3T3 cells was tested. It was found that H-RasV12
was able to robustly induce cellular transformation from most
of the cellular localizations where it was targeted (Fig. 6C),
slightly more prominently from PM microdomains, both lipid
rafts and bulk membrane, than from endomembranes such as
the ER. Conversely, Golgi complex-tethered KDELr-V12 was
incapable of promoting cellular transformation to any extent.
Summing up, these sets of experiments clearly demonstrated
that, depending on the subcellular compartment at which it
was located, activated H-Ras could trigger proliferation, sur-
vival, and transformation to different extents.
Effects of site-specific Ras inhibition on cellular prolifera-
tion and transformation. The aforementioned results clearly
supported the notion that sublocalization dictates Ras signal out-
put and its biological consequences. However, these sets of ex-
periments explored how compartmentalization influenced the ef-
fects of constitutive Ras signals and did not provide an answer as
to how necessary Ras is at its different localizations for the con-
veyance of upstream signals that drive cellular proliferation or
FIG. 6—Continued.
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transformation. To address this important point, we designed a
strategy to selectively inhibit Ras activity at defined sites. We have
previously demonstrated that the inhibitory specificities of Ras
N17 dominant inhibitory mutants are related to their microlocal-
ization, in such a way that a N17 mutant acting at a defined
microdomain, will inhibit all Ras molecules therein irrespective of
the isoform (35). Thus, we reasoned that specifically targeting
H-RasN17 to defined localizations, by using the aforementioned
tethering cues, could be an effective method to block Ras func-
tions in a site-specific fashion.
To begin with, we verified the site inhibition specificity of our
targeted H-RasN17 constructs. Inhibition at the ER was tested in
COS-7 cells by assaying GTP loading in ER-tethered M1-H-Ras,
induced by the guanine nucleotide exchange factor RasGRF1, in
the presence of the inhibitory constructs M1-N17 and CD8-N17.
It was found that GDP/GTP exchange in M1-H-Ras was abro-
gated by ER-tethered M1-N17, but not by bulk membrane-tar-
geted CD8-N17 (Fig. 7A, left panel). As a negative control M1-
green fluorescent protein (GFP) was used to validate that the
inhibition was specific for RasN17 and that it was not an unspe-
cific effect due to M1 tethering signal. Conversely, when GTP
loading was assayed on bulk membrane-tethered CD8-H-Ras,
this was inhibited by CD8-N17 but not by M1-N17 (Fig. 7A, right
panel). Similar results were obtained when testing for the cross-
inhibitory effects of most N17 constructs (data not shown),
thereby demonstrating that the inhibitory effects of the targeted
N17 mutants were site specific. Only in one instance cross-inhi-
bition was evident. This was when nucleotide exchange was as-
sayed in lipid raft-tethered LCK-H-Ras that could be inhibited
both by LCK-N17 and by CD8-N17 (Fig. 7B, left panel). Like-
wise, GTP loading in bulk membrane CD8-H-Ras could be in-
hibited by CD8-N17 and, to a lesser extent, by LCK-N17 as well
(Fig, 7B. right panel).
Next, we studied the effects of the targeted N17 mutants on
cellular proliferation by testing their ability to interfere with col-
ony growth. As such, NIH 3T3 cells were transfected with the
targeted N17 constructs and, after culture under G418 selection,
the resulting colonies were scored. As shown in Fig. 7C, ER-
targeted M1-N17 and bulk membrane-targeted CD8-N17 ro-
bustly restricted growth, showing more than 66% reduction com-
pared to the number of colonies formed by H-Ras wild-type, a
decrease comparable to that one brought about by untargeted
H-RasN17. On the other hand, Golgi complex-tethered KDELr-
N17 had minimal effects on colony proliferation. Interestingly,
LCK-N17, in spite of its cross-interference with Ras activation at
bulk membranes, was considerably less efficient than CD8-N17
for restricting colony numbers, reducing it by only 30%. These
results hinted that only Ras functions at the ER and at bulk
membrane were essential for supporting cellular growth.
We then investigated the effects of site-restricted Ras inhi-
bition on cellular transformation. To do this, we analyzed in
NIH 3T3 fibroblasts the transforming potential of different
types of oncogenes, when Ras was inhibited at some specific
site by cotransfection with the targeted N17 mutants. Since Ras
N17 mutants function by unproductively sequestering ex-
change factors (19), they should not affect Ras V12-evoked
events. As such, the concentration of the constructs encoding
for the N17 mutants was adjusted so as to minimally interfere
with transformation induced by H-RasV12, thereby avoiding
nonspecific, inhibitory effects. Under these conditions, transfor-
mation by a PM-bound tyrosine kinase such as v-Src proved to be
particularly sensitive to Ras inhibition at the PM, in particular at
the bulk membrane. Noticeably, Ras inhibition at the ER had
little effects on v-Src-induced transformation (Table 1). In the
case of v-Sis, encoding for a growth factor, platelet-derived
growth factor (PDGF), which acts through a tyrosine kinase re-
ceptor, blocking Ras functions at the PM markedly reduced its
transforming potential, 73% blockade by bulk membrane CD8-
N17 and 53% by LCK-N17 at lipid rafts. On the other hand,
inhibiting Ras ER pool had only moderate consequences on v-Sis
transformation, preventing it by only 25%. A very similar situa-
tion was encountered when we evaluated transformation by the G
protein-coupled receptor, m1 muscarinic receptor, an agonist-
dependent oncogene, in the presence of its ligand carbachol (20).
Interestingly, blocking Ras activation at the Golgi complex by
KDELr-N17 had very modest effects on the transforming poten-
tial of all of the oncogenes tested (Table 1).
Cells devoid of Ras at lipid rafts and at the Golgi complex
proliferate normally and can be transformed. The fact that our
N17 constructs tethered to bulk membrane and to lipid rafts
exhibited some degree of cross-inhibition precluded us from gain-
ing a clear picture of the necessity for Ras functions at these
microdomains. In order to clarify this point, we resorted to an
alternative experimental model. This was provided to us by the
existence of double-knocked-out mice for H-Ras and N-Ras (18).
Cells derived from these mice express only the isoform K-Ras, but
since K-Ras is not found in lipid rafts (39) these are completely
devoid of all Ras isoforms, thus constituting an unambiguous
model for our purposes. In addition, cells derived from H-Ras/
N-Ras double-knockout mice also lack Ras at the Golgi complex,
since K-Ras is also absent from this organelle (1, 11).
First of all, we ascertained that in MEFs from H-Ras/N-
Ras	/	 mice, K-Ras had not undergone a redistribution pro-
cess due to adaptive pressures and lipid rafts and the Golgi
complex were indeed devoid of every Ras isoform. Double
immunofluorescence analysis of H-Ras with the lipid raft
marker GM1 and the Golgi marker giantin verified the com-
plete lack of expression of H-Ras in these cells (Fig. 8A and B).
Identical results were obtained when we analyzed the expres-
sion of N-Ras (data not shown). When the distribution of
K-Ras was analyzed, it was found that this isoform was noto-
riously present at the ER and at some PM localizations (Fig.
8C). However, upon double staining with GM1 an absolute
lack of colocalization was evident, a finding indicative of the
absence of K-Ras from lipid rafts. Likewise, coimmunofluores-
cence with giantin revealed the complete exclusion of K-Ras
from the Golgi complex (Fig. 8D). The absence of cross-reac-
tivity among the different Ras isoforms and the GTPase TC-
21-specific antibodies utilized in our assays was ascertained to
further confirm our data (Fig. 8E). These results clearly cor-
roborated the absence of Ras isoforms from lipid Rafts and the
Golgi complex in H-Ras/N-Ras	/	 MEFs.
The mere fact that H-Ras/N-Ras	/	 mice are viable and
grow normally (18) was an indisputable proof of Ras functions
at lipid rafts and the Golgi complex being completely super-
fluous for normal cell growth and made further experimenta-
tion on this respect unnecessary. So we proceeded to test the
need for Ras at these sites in the process of cellular transforma-
tion. Thus, we tested the ability of oncogenes to transform H-Ras/
N-Ras	/	 MEFs. Since MEFs in order to be transformed require
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the additional participation of a nuclear oncogene, c-Myc was
cotransfected in all cases. As expected, H-Ras V12 displayed a
potent focus-forming activity. Interestingly, this was also the case
for v-Src and for m1 receptor (Fig. 8F). Furthermore, these on-
cogenes were able to transform H-Ras/N-Ras	/	 MEFs in pro-
portions similar to those of the wild-type MEFs (data not shown).
Therefore, these results clearly corroborated that the functions
undertaken by Ras at lipid rafts and the Golgi complex were fully
dispensable for cellular growth and transformation.
DISCUSSION
Today, a large body of evidence supports the notion that Ras
proteins are segregated throughout different PM microdo-
mains and internal membrane systems (23). Determining how
compartmentalization influences Ras signaling and its subse-
quent biochemical and biological effects undoubtedly repre-
sents a conceptual milestone in the long quest for unraveling
the fine points of Ras mechanics. Ideally, one would attempt to
selectively activate or inhibit endogenous Ras at a particular
compartment. However, our current state of knowledge and
technical limitations preclude such an untainted approach.
Thus, we are forced to resort to alternative strategies that,
though less sophisticated, will enable us to gain a timely insight
into this conundrum.
We have approached the problem by selectively targeting
H-RasV12 to those cellular compartments where Ras is local-
ized under physiological conditions. This we have achieved by
substituting H-Ras palmitoylation signal for N-terminally
fused peptides encoding for alternative cues that specifically
direct Ras to the desired locations. These proteins have been
FIG. 7. Inhibitory specificity of targeted RasN17 mutants. (A) Inhibition of Ras-GRF-induced Ras activation at the ER and bulk membrane
by tethered N17 mutants. The left panel shows inhibition of Ras activation at the ER. Cos-7 cells were cotransfected with Ras-GRF (1 g) and
M1-H-Ras (1 g) in addition to CD8-N17, M1-N17, and M1-GFP (0.5 g) where indicated. M1-H-Ras GTP levels of a representative experiment
are shown, as determined by anti-HA immunoblotting in affinity precipitates using GST-Raf-RBD. Ras-GRF levels were determined in total lysates
by using anti-Ras-GRF antibodies, and the levels of CD8- and M1-N17 mutants were monitored with anti-FLAG antibody. The right panel shows
inhibition of Ras activation at the bulk membrane. (B) Inhibition of Ras-GRF-induced Ras activation at lipid rafts and bulk membrane by tethered
N17 mutants. The left panel shows inhibition of Ras activation at lipid rafts. Cos-7 cells were cotransfected with Ras-GRF (1 g) and LCK-H-Ras
(1 g) in addition to CD8-N17 and LCK-N17 (0.5 g) where indicated. LCK-H-Ras GTP levels of a representative experiment are shown.
Ras-GRF levels were determined in total lysates using anti-Ras-GRF antibodies. The right panel shows inhibition of Ras activation at the bulk
membrane. The figures indicate average levels of activation of at least five independent experiments relative to controls. (C) Effects of targeted
Ras N17 mutants on colony growth. NIH 3T3 fibroblasts were transfected with the indicated N17 constructs or with H-Ras (wt) (0.5 g). Cells were
grown in the presence of G418 (750 g/ml). After 2 weeks in culture, colonies were stained and scored. The results show average  the SEM of
at least five independent experiments.
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stably expressed in NIH 3T3 cells, and their correct localiza-
tion has been extensively corroborated. It is noteworthy the
fact that we have encountered very little mislocalization and
unwanted intercompartment spillage. This was particularly
striking in the case of experiments using transient transfections
in COS-7 or 293T cells, in which plasmid episomal replication
yields very high protein levels, in spite of which mislocaliza-
tions were seldom detected. In this respect, we have observed
that there are slight variations in the levels of targeted Ras
proteins present at the different localizations. This probably
reflects that distinct types of membranes support different
amounts of Ras. In support of this notion we have observed
that the expression levels of our targeted Ras constructs are
dependent on the Ras farnesylation signal. A likely explanation
for the absence of mislocalizations could be that once Ras-
binding sites at a given location are saturated, excess targeted-
Ras proteins, bearing a farnesyl moiety that cannot be inserted
into a membrane, are rapidly degraded. In agreement, we have
observed that farnesylation-deficient, targeted Ras proteins ac-
cumulate in the cytoplasm when overexpressed. Regardless of
the targeting signal utilized, there will be a limit to how much
protein can be inserted into a given site, after which surplus
will accumulate in the cytoplasm and/or will be degraded. In
the case of our constructs that limit is set by the availability of
Ras-binding sites.
We have thoroughly ascertained the specificity of Ras tar-
geting to bulk membrane and to lipid rafts. This we have
monitored by immunofluorescence, detergent solubilization,
and lysis in sodium carbonate. The three methods have dem-
onstrated specific targeting and a complete absence of cross-
FIG. 8. MEFs devoid of Ras at lipid rafts can be transformed. H-Ras/N-Ras	/	 MEFs are devoid of Ras isoforms at lipid rafts and the Golgi complex.
MEFs were costained with anti-H-Ras antibodies (red, panel A; green, panel B) or anti-K-Ras (red, panels C and D) and cholera toxin to stain lipid rafts
(green, panels A and C) or the Golgi marker antigiantin (red, panel B; green, panel D). All panels show equatorial sections at the cell nucleus level. Bars:
A and C, 20 m; B and D, 10 m. (E) Specificity of the antibodies utilized. Lysates from COS-7 cells transfected with H-Ras (H), K-Ras (K), N-Ras
(N), and TC-21 (TC) were immunoblotted with the indicated antibodies. (F) H-Ras/N-Ras	/	 MEF transformation induced by oncogenes. MEFs were
transfected with vectors encoding for H-Ras V12, v-Src, or m1 muscarinic receptor (1 g each), in addition to c-Myc (1 g). After 3 weeks, cells were
stained, and the number of foci was scored. m1-transfected plates were grown in the presence of 10 M carbachol.
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localization. We have observed that the constructs that are
targeted to bulk membrane and to lipid rafts can also be
detected in small cytoplasmic vesicles, probably bulk mem-
brane and lipid raft-derived endosomes. This phenomenon is
highly representative of the internalization and recycling pro-
cesses that take place at the PM. However, it prevents us from
finely discriminating between events strictly taking place at
these microdomains and those that occur at their derived en-
dosomes, which would constitute the next level of complexity
in our future investigations. At this stage, we have limited
ourselves to gain an overall view of the processes regulated by
Ras proteins that reside in these membrane subtypes, irrespec-
tive of the stage of the membrane turnover cycle. Without
interfering with the physiological trafficking and recycling pro-
cesses that these subdomains are subject to, that could lead to
confusing situations.
We have verified that our constructs are functional. In spite
of the variable-size peptides that were fused to their N termini,
all RasV12 constructs bound with similar efficiencies to an
effector molecule in vitro, indicating that the N-terminal struc-
tural alterations did not affect their GTP-bound state. This was
further corroborated in vivo by their ability to recruit c-Raf to
those sites where they had been tethered. A notorious excep-
tion was the case of the Golgi complex, in which very little
colocalization of c-Raf and KDELr-V12 was observed. This
observation is in full agreement with our results showing that
FIG. 8—Continued.
TABLE 1. Effects of compartmentalized Ras inhibition on cellular transformationa
Oncogene
Avg no. of foci/g of oncogene DNA  SEM (% inhibition)
Vector N17 M1 N17 Lck N17 CD8 N17 KDELr N17
H-Ras V12 3,270  126 3,002  165** (	9) 2,981  90** (	9) 3,182  125NS (	3) 2,943  79** (	10) 3,197  105NS (	3)
v-Src 402  31 304  25** (	25) 414  46NS (3) 246  47*** (	39) 194  61*** (	52) 433  38NS (8)
v-Sis 414  83 221  29*** (	47) 322  40* (	23) 179  34*** (	57) 112  48*** (	73) 378  48NS (	9)
m1 MAchR 774  92 487  42*** (	38) 534  75*** (	23) 480  30*** (	32) 464  93*** (	41) 825  33NS (	10)
a NIH 3T3 fibroblasts were cotransfected with H-RasV12 (100 ng), v-Src (1 g), v-Sis (1.5 g), or m1 receptor (0.5 g) in addition to the different N17 targeted
constructs (0.5 g) where indicated. After 2 weeks, cells were stained, and foci were scored. Figures, expressed as foci per micrograms of oncogene DNA, indicate the
average  the SEM of at least four independent transfections. The percent inhibitions relative to vector-transfected plates are shown in parentheses. m1-transfected
plates were grown in the presence of 10 M carbachol. Analysis of variance was determined by Bonferroni multiple comparisons test relative to the respective “vector”
values. P values: , P  0.05; , P  0.01; , P  0.001; NS, P  0.05 with a 95% confidence interval.
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activation of the ERK cascade at the Golgi complex was very
poor and may reflect either the lack of c-Raf at Golgi micro-
localizations where Ras is present or, alternatively, the absence
therein of scaffold proteins that intervene in the assembly of
the Ras-Raf complex. Even though during mitosis the presence
of Raf at the Golgi complex and its participation in Golgi
fragmentation has been reported (12), whether Raf is directly
activated therein or elsewhere and then shuttles to that or-
ganelle has not been demonstrated.
Our results clearly demonstrate that the intensity at which
an effector route is activated by Ras is greatly dependent on its
localization. It is unlikely that differences in Ras concentra-
tions can account for the observed variations. For example, the
potential to engage effectors and the robustness of the biolog-
ical outcomes of M1-V12 are some of the greatest, even though
its expression levels are not as high as those of LCK-V12 or of
CD8-V12. Furthermore, at any given compartment some ef-
fector routes are very efficiently stimulated, while others are
not. Probably, the local intensity of a signal is dictated by the
limited availability of some or all of the intermediaries that
build up a signaling module or of essential scaffold proteins
that optimize signal output through that route. In line with this
notion, our results demonstrate that the Ral-GDS route is
most efficiently stimulated at the Golgi complex where high
concentrations of its cognate GTPase, RalA, are found (31).
Likewise, the Raf-ERK pathway is preferentially activated in
lipid rafts, reflecting c-Raf high affinity for cholesterol-en-
riched domains (30). Even though this result may seem con-
trary to previous reports, indicating that Raf activation is fa-
vored in bulk membrane as opposed to lipid rafts (39), Raf
activation can be initiated at lipid rafts (44) and lipid raft
disruption prevents the activation of the Raf-ERK pathway
(43, 47), indicating that the machinery to activate this pathway
is readily available at lipid rafts. The fact that we are using fixed
Ras constructs, unable to translocate between compartments,
could account for the differences in signal intensities reported
here and in previous reports (39).
We have found that Ras can effectively support cellular
proliferation and transformation from most of its platforms.
Since a biological output is the result of the integration of all
of the signals generated by a causative stimulus, it is difficult, if
not impossible, to discretely associate a biological outcome
with the activation of a particular route. However, our results
underscore the importance of two essential factors. (i) The first
is the signal intensity. How Ras signal strength affects the
biological outcome(s) is highlighted by the behavior of the cells
harboring M1-V12 and RasV12 SS. Both of them operate at
the ER, and both activate the same signaling pathways, M1-
V12 more intensively in all cases. As such, M1-V12 is much
more effective in promoting proliferation, transformation, and
survival. It is noteworthy that signal intensity does not follow a
proportional relationship with the resulting biological out-
come(s), which hints the existence of signal thresholds over
which full biological responses would ensue. (ii) The second
factor is the availability of substrates. We show here that only
the ER Ras pool can sustain cell survival, even though Ras
operating from other platforms, for example, lipid rafts, evokes
very similar effectors usage and almost identical signal inten-
sities. One likely explanation for this apparent discrepancy
could be that ERK/Akt/Ral substrates mediating in cell sur-
vival are confined and available mainly to ER-activated ef-
fectors.
The surprising finding of the Ras ER pool being extremely
efficient at supporting survival is completely unprecedented.
Our results reveal that M1-V12 generates a potent antiapo-
ptotic signal irrespective of the cell type and the apoptogenic
stimulus. Interestingly, M1-V12 evokes antiapoptotic events
that H-Ras V12 cannot. One possible explanation for this
could be that M1-V12 is fixed to the ER, whereas H-Ras V12
is subject to Ras physiological trafficking in and out of the ER.
Therefore, it is conceivable that by increasing Ras residence
time at this organelle a more efficient pro-survival signaling
could be elicited. Even though the exact mechanisms whereby
this process takes place are unknown, the ER is a key site
directly intervening in the apoptosis-regulating effects of cal-
cium (21). Interestingly, N-Ras, known to provide a potent
antiapoptotic signal (51), is particularly abundant at the ER
(our unpublished results).
Our results indicate that Ras activation at the Golgi complex
cannot promote cellular transformation nor enhance cell pro-
liferation, even though it is competent for sustaining limited
cellular growth for short periods under serum starvation con-
ditions. This clearly contrasts with previous reports (7, 10).
However, one technical subtlety may likely account for this
discrepancy: we utilized here as a Golgi complex-tethering
signal KDELr, harboring the mutation N193D that prevents it
from translocating to the ER and fixes it to the Golgi complex
as a permanent resident protein (13). In contrast, the afore-
mentioned studies used KDELr wild type. As such, proteins
tethered with this cue will shuttle between ER and the Golgi
complex. Since Ras at the ER can effectively transform, as we
and others have shown (10), it is very likely that transformation
elicited by KDELr wild-type-tethered Ras is a consequence of
its transit through the ER. In full agreement with our results,
a former report using yet another Golgi complex-targeting
signal, the E1 protein of avian bronchitis virus, detected no
transformation induced by Ras at the Golgi complex (28). On
the other hand, in light of our data demonstrating the potent
activation of RalGDS by Ras at the Golgi complex and of
previous studies reporting the importance of this pathway for
human oncogenesis (22, 41), it is conceivable that, in contrast
to the murine model, Ras at the Golgi complex could play an
important role in the transformation of human cells.
The fact that mutationally activated Ras can effectively exert
its effects from most of the sites where it is found, provides
little information on the relevance and need for endogenous
Ras at its different compartments in processes such as physio-
logical proliferation and transformation by upstream stimuli.
We have addressed this issue here, specifically blocking endog-
enous Ras pools by tethering thereto inhibitory N17 mutants.
Remarkably, these mutants have yielded highly specific site-
restricted inhibitory effects, the sole exception being N17s tar-
geted to lipid rafts and to disordered membrane, which exhib-
ited some degree of cross-inhibition. However, this should not
be surprising. The ER and the Golgi complex are tangible,
isolated structures, and most of their extension is spatially
separated from each other and from the PM. Thus, it is
conceivable that mutants targeted thereto can only exert
their effect locally, without interfering with Ras GEFs at
other confinements sufficiently separated. On the other
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hand, lipid rafts and bulk membrane are contiguous do-
mains, exhibiting diffuse boundaries. As such, it can be en-
visioned that lipid raft-targeted N17 can deprive adjacent
bulk membrane of its GEFs and vice versa. The fact that
CD8-N17 displays a greater cross-inhibitory potential than
LCK-N17 could be a reflection of a greater proportion of
the PM being constituted by bulk membrane (27).
Using these constructs we have shown that blocking Ras at
the ER and at bulk membrane has profound inhibitory effects
on cellular proliferation. On the other hand, abrogating Ras
activity at lipid rafts or at the Golgi complex had discrete
effects on cell growth. These results have been corroborated in
an alternative model: embryo fibroblasts derived from H-Ras/
N-Ras double-knockout mice (18). As far as our detection
limits enabled us to, we ascertained that, in these cells, lipid
rafts and Golgi complex were indeed devoid of Ras isoforms.
As such, the sheer fact that H-Ras/N-Ras	/	 mice grow and
reproduce normally proves beyond doubt that Ras functions at
these sites are absolutely dispensable for cellular proliferation
under physiological conditions. Since these cells only express
K-Ras, which is located at disordered membrane (39), these
results add further support to the notion that, at the PM, the
main Ras signals originate from this microdomain (23). In
addition, our results point to an endomembrane, the ER, as
another site at which Ras functions are essential for prolifer-
ation. In line with our results demonstrating that most effector
pathways are effectively engaged from this signaling platform.
Finally, we have also investigated the importance of com-
partmentalized Ras functions for cellular transformation when
induced by upstream stimuli. To do so, we scored the trans-
forming potential of different oncogenes when localized Ras
pools were specifically suppressed by N17 mutants. We have
observed that some targeted N17 mutants are more effective
for inhibiting transformation than untargeted H-RasN17. A
possible explanation could be that the expressed H-RasN17
proteins are dispersed between compartments essential and
nonessential for transformation, whereas the same amounts of
targeted N17s are concentrated at specific sites. This provides
an indication of the necessity of Ras at a particular compart-
ment for transformation. As such, our results indicate that Ras
at the Golgi complex is not essential for the transmission of
upstream transforming signals. Interestingly, even though our
previous results pointed to the Ras ER pool as necessary for
proliferation, its suppression had only moderate inhibitory ef-
fects on transformation. How transforming oncoproteins can
circumvent the requirement for Ras ER functions is thus far
unknown. With respect to PM microdomains, our results dem-
onstrate the dispensability of Ras lipid raft pool for transforma-
tion elicited by upstream oncoproteins. v-Sis cognate receptor
PDGFr, Src, and most G protein-coupled receptors are prefer-
entially located in lipid rafts (32, 36, 42). Interestingly, in oligo-
dendrocytes PDGFr is sequestered in a raft domain at a devel-
opmental stage in which PDGF does not promote proliferation
(6). Our results suggest that these oncoproteins can exert their
effects in the absence of Ras in lipid rafts. This could be due to
either contiguous bulk membranes being sufficiently close as to be
capable of activating Ras therein or to the fact that some active
pools of these proteins also reside in bulk membrane. Once again
in full agreement with previous results (23), our data highlights
the importance of bulk membrane microdomains in Ras signal-
ing.
Overall, our results underscore for the first time the vari-
ability of Ras biochemical signals depending on the signaling
platform. Noticeably, we demonstrate that mutationally acti-
vated Ras can support enhanced cellular proliferation and
transformation from most sites. This has special connotations
regarding carcinogenesis, indicating that strategies aimed at
inhibiting Ras localization at the PM will not prevent Ras
transforming effects elicited from alternative sites such as the
ER. In addition, our results highlight the importance of Ras
signaling at bulk membrane and provide compelling evidence
on the dispensability of Ras functions at lipid rafts and the
Golgi complex under physiological conditions.
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